AIDS Therapies
FDA Authorizes Protocol in Multi-Drug Resistant Disease
Published in AIDS Weekly, September 18th, 2000
The clinical study will involve 100 patients residing in the continental United States. Candidate patients exhibit multi-drug resistance to other antivirals, which have previously received full marketing authorization and are already in general use.
The Hemispherx protocol is designed to potentially treat multi-drug resistance, which is due to numerous HIV genomic mutations, or genetic rearrangements. The mutations eliminate the standard...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2000-09-18)
More Articles from AIDS Weekly
- HIV Pathogenesis
HIV Specific Unresponsiveness May Play Role in Diminished T-Cell Production - AIDS Therapies
Adenine Induces Selective Apoptosis of HIV Infected Cells in vitro - AIDS Therapies
HAART Reduces Anemia in HIV Infected Women - Androgen Deficiency
Transdermal Testosterone Replacement Effective for HIV Infected Women - Endocrinology
Drug Abuse, Not HIV Infection, Responsible for Changes in Reproductive Hormones in HIV+ Women - HIV Pathogenesis
Lentivirus Infection Induces Matrix Metalloproteinase Expression in Brain - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
